Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Urine test predicts Alzheimer’s disease

14.06.2002


A simple clinical test could make it easier to track and treat Alzheimer’s



A urine sample taken at the doctor’s office can be the step in determining your chances of developing Alzheimer’s disease (AD), according to researchers at the University of Pennsylvania School of Medicine. They have determined that a urine test can reliably detect free radical damage associated with people with Mild Cognitive Impairment (MCI) – a recognized precursor to AD. The test detects isoprostanes, fatty acids that are formed as the result of free radical damage in the brain – damage that correlates with clinical diagnosis of AD.

"This is the first noninvasive test that can predict a clinical diagnosis of Alzheimer’s disease," said Domenico Praticò, MD, assistant professor in Penn’s Department of Pharmacology. "Since there is no cure for Alzheimer’s disease, physicians could slow the course of the disease if it is caught early enough."


Within four years of initial diagnosis, up to 50% of people with MCI develop Alzheimer’s disease. As AD progresses, it attacks the brain and causes severe damage in the areas important for memory, judgement, and language. This destruction leads to other clinical complications and, eventually, death.

In the study, published in the June edition of Archives of Neurology, Praticò and his colleagues measured isoprostane in blood and urine samples obtained from 50 patients with a clinical diagnosis of AD, 33 patients with MCI, and 40 healthy volunteers. Two weeks later, a CSF sample and a second urine sample were taken from 28 of the AD patients, 17 of the MCI patients, and 18 of the control subjects. The researchers found significantly higher levels of isoprostane in CSF, blood, and urine of MCI and AD subjects than in the volunteers. Remarkably, the samples taken from the MCI subjects and the volunteers differed only in respect to their isoprostane levels.

"We found that patients with MCI have increased brain oxidative damage before the onset of AD – damage that can be detected in the form of isoprostanes in urine, as this study shows," said Praticò. "In fact, five MCI subjects, all with high isoprostane levels, converted to AD during follow-up."

Patients that are diagnosed with Mild Cognitive Impairment typically present their physicians with persistent memory loss that is not normal for someone of their age and education. Although their memory is impaired, MCI patients are capable of living largely independent lives. At this stage, it is difficult to determine whether a person with MCI will eventually have Alzheimer’s or whether they will progress to a form of unrelated dementia.

A urine sample taken in the doctor’s office may be a first point of decision in gauging the risk of developing AD. Further tests could then determine the severity of a patient’s condition and course of treatment. For example, studies have shown that the transition from MCI to AD occurs fastest in people who have a gene called apoE4 and whose brain’s hippocampus region is shown to be smaller as measured in an MRI scan.

"One hypothesis is that, in AD, healthy brain tissue is damaged by the local formation of large amounts of free radicals," said Praticò. "Isoprostanes are the byproducts of fats in the human body that were warped by free radical attack. They then accumulate in CSF, blood, and urine as the body works to get rid of them."

While at the moment this test is not yet clinically available, the team is working on the development of a version of it that could be broadly and easily performed.

Unlike a spinal tap, a urine test is simple to do and provides a painless and noninvasive way of assessing the situation. "The advantages are clear: with an easier test, doctors can diagnose the disease sooner and respond better to the patient’s needs," said Praticò.


This research was supported by grants from the National Institutes of Health and the American Heart Association. Trial participants were selected at the Memory Disorders Clinic of Penn’s Alzheimer’s Disease Center.


Greg Lester | EurekAlert

More articles from Health and Medicine:

nachricht Collagen nanofibrils in mammalian tissues get stronger with exercise
14.12.2018 | University of Illinois College of Engineering

nachricht New discoveries predict ability to forecast dementia from single molecule
12.12.2018 | UT Southwestern Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Data use draining your battery? Tiny device to speed up memory while also saving power

The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.

Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...

Im Focus: An energy-efficient way to stay warm: Sew high-tech heating patches to your clothes

Personal patches could reduce energy waste in buildings, Rutgers-led study says

What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...

Im Focus: Lethal combination: Drug cocktail turns off the juice to cancer cells

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...

Im Focus: New Foldable Drone Flies through Narrow Holes in Rescue Missions

A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.

Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...

Im Focus: Topological material switched off and on for the first time

Key advance for future topological transistors

Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

ICTM Conference 2019: Digitization emerges as an engineering trend for turbomachinery construction

12.12.2018 | Event News

New Plastics Economy Investor Forum - Meeting Point for Innovations

10.12.2018 | Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

 
Latest News

Data use draining your battery? Tiny device to speed up memory while also saving power

14.12.2018 | Power and Electrical Engineering

Tangled magnetic fields power cosmic particle accelerators

14.12.2018 | Physics and Astronomy

In search of missing worlds, Hubble finds a fast evaporating exoplanet

14.12.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>